Skip to main content
Clinical Trials/IRCT20211118053093N6
IRCT20211118053093N6
Not yet recruiting
Phase 2

Investigating the efficacy of Levetiracetam adjunct to Olanzapine for acute manic episode of bipolar disorder, a Double-blind placebo controlled randomized clinical trial

Shiraz University of Medical Sciences0 sites60 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Bipolar disorder type one.
Sponsor
Shiraz University of Medical Sciences
Enrollment
60
Status
Not yet recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • BID diagnosis based on DSM\-V criteria
  • Y\-BOCS score equal or more than 20

Exclusion Criteria

  • Medical problems

Outcomes

Primary Outcomes

Not specified

Similar Trials